Zobrazeno 1 - 10
of 145
pro vyhledávání: '"J Kottakis"'
Publikováno v:
Canadian Respiratory Journal, Vol 6, Iss 5, Pp 412-416 (1999)
BACKGROUND: In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single-dose device (Foradil, Aerolizer), and the other uses a multiple-dose device (Oxis, Turbuhaler).
Externí odkaz:
https://doaj.org/article/e1430a6091cb47b49932345a45924e6c
Publikováno v:
Revista Portuguesa de Pneumologia, Vol 10, Iss 5, Pp 448-450 (2004)
RESUMO: As normas internacionais para o tratamento da asma brônquica recomendam que os doentes com sintomatologia mal controlada com doses baixas/ /intermédias de corticosteróides (CT) inalados sejam submetidos a doses mais elevadas de CT e,
Externí odkaz:
https://doaj.org/article/35946210e64548bab637bc5adad3933b
Publikováno v:
Revista Portuguesa de Pneumologia, Vol 9, Iss 3, Pp 448-450 (2003)
RESUMO: As normas internacionais para o tratamento da asma brônquica recomendam que os doentes com sintomatologia mal controlada com doses baixas/ /intermédias de corticosteróides (CT) inalados sejam submetidos a doses mais elevadas de CT e,
Externí odkaz:
https://doaj.org/article/5adea7ff9b0d4819b089b5ab2b24d2e0
Publikováno v:
International Journal of Clinical Practice. 55:476-479
Autor:
A Eliraz, A Ramirez‐Rivera, P Ferranti, R Holzer, JM Ignacio Garcí, C Turcotte, G Rapatz, P Pfister, T Overend, J Kottakis
Publikováno v:
International Journal of Clinical Practice. 55:164-170
Publikováno v:
Europe PubMed Central
Canadian Respiratory Journal, Vol 6, Iss 5, Pp 412-416 (1999)
Canadian Respiratory Journal, Vol 6, Iss 5, Pp 412-416 (1999)
BACKGROUND: In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single-dose device (Foradil, Aerolizer), and the other uses a multiple-dose device (Oxis, Turbuhaler).OBJECTIVES: To study the
Publikováno v:
Revista Portuguesa de Pneumologia, Vol 10, Iss 5, Pp 448-450 (2004)
Revista Portuguesa de Pneumologia, Vol 9, Iss 3, Pp 448-450 (2003)
Revista Portuguesa de Pneumologia, Vol 9, Iss 3, Pp 448-450 (2003)
RESUMO: As normas internacionais para o tratamento da asma brônquica recomendam que os doentes com sintomatologia mal controlada com doses baixas/ /intermédias de corticosteróides (CT) inalados sejam submetidos a doses mais elevadas de CT e,
Autor:
Wang, Yina1 (AUTHOR) ruily@umich.edu, Rui, Liangyou1,2 (AUTHOR)
Publikováno v:
Onco. Sep2024, Vol. 4 Issue 3, p217-231. 15p.
Autor:
J F, Muir, D, Benhamou, A, Cuvelier, V, Le Gros, T, Overend, D, Till, G, Della Cioppa, J, Kottakis
Publikováno v:
International journal of clinical practice. 58(5)
Evaluation of patients with chronic obstructive pulmonary disease (COPD) often includes the use of post-bronchodilator reversibility testing to guide treatment decisions. Recommendations for reversibility testing differ and there is no universally ac
Publikováno v:
Pulmonary pharmacologytherapeutics. 16(5)
This double-blind, randomised, multi-centre, parallel-group study compared the effect of adding Foradil (formoterol fumarate) to existing medium-high doses of inhaled corticosteroids (ICS) with that of doubling the dose of ICS in patients with sub-op